In the BioHarmony Drug Report Database
Guanabenz
Wytensin (guanabenz) is a small molecule pharmaceutical. Guanabenz was first approved as Wytensin on 1982-09-07. It is used to treat hypertension in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor, alpha-2C adrenergic receptor, and alpha-2A adrenergic receptor.
Trade Name
|
Wytensin |
|---|---|
Common Name
|
guanabenz |
ChEMBL ID
|
CHEMBL420 |
Indication
|
hypertension |
Drug Class
|
Cannabinol derivatives; antihypertensives (guanidine derivatives) |
Image (chem structure or protein)